Cargando…
Patient Selection for Renal Denervation in Hypertensive Patients: What Makes a Good Candidate?
Renal denervation (RDN) as a therapeutic intervention in patients with hypertension has been intensively studied for over a decade, yet a critical question remains unanswered: what kind of patients are the ideal target population for RDN to achieve its maximum clinical benefit? We herein provide a r...
Autores principales: | Li, Sheran, Phillips, Jacqueline K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113553/ https://www.ncbi.nlm.nih.gov/pubmed/35592729 http://dx.doi.org/10.2147/VHRM.S270182 |
Ejemplares similares
-
Renal denervation does not affect hypertension or the renin-angiotensin system in a rodent model of juvenile-onset polycystic kidney disease: clinical implications
por: Li, Sheran, et al.
Publicado: (2021) -
Renal Sympathetic Denervation for Hypertension
por: Guber, Kenneth, et al.
Publicado: (2022) -
Renal denervation for the management of resistant hypertension
por: Patel, Hitesh C, et al.
Publicado: (2015) -
Renal denervation as an option for the management of hypertension
por: Santiapillai, Georgina Radhini, et al.
Publicado: (2014) -
Renal Denervation in Hypertensive Patients: Back to Anatomy?
por: Persu, Alexandre, et al.
Publicado: (2020)